28498873|t|Associations of androgens with depressive symptoms and cognitive status in the general population
28498873|a|Associations between androgens and depressive symptoms were mostly reported from cross-sectional and patient-based studies. Longitudinal data from 4,110 participants of the Study of Health in Pomerania were used to assess sex - specific associations of baseline total and free testosterone, androstenedione and sex hormone-binding globulin with incident depressive symptoms and cognitive status at 5- and 10- year follow-up. Despite sex - specific differences in depressive symptoms prevalence at baseline (women: 17.4%, men: 8.1%), cross-sectional analyses showed no associations between sex hormones and depressive symptoms. In age-adjusted longitudinal analyses, total testosterone was associated with incident depressive symptoms (relative risk at 5- year follow-up: 0.73, 95% confidence interval: 0.58-0.92). Similarly, age-adjusted analyses showed a positive association between sex hormone-binding globulin and cognitive status in men (β-coefficient per standard deviation: 0.44, 95% confidence interval: 0.13-0.74). In women, age-adjusted associations of androstenedione with baseline depressive symptoms (relative risk: 0.88, 95% confidence interval: 0.77-0.99) were found. None of the observed associations remained after multivariable adjustment. The present population-based, longitudinal study revealed inverse associations between sex hormones and depressive symptoms. However, the null finding after multivariable adjustment suggests, that the observed associations were not independent of relevant confounders including body mass index, smoking and physical inactivity. Furthermore, the low number of incident endpoints in our non-clinical population-based sample limited the statistical power and reduced the chance to detect a statistically significant effect.
28498873	0	12	Associations	T080	C0439849
28498873	16	25	androgens	T121,T125	C0002844
28498873	31	50	depressive symptoms	T184	C0086132
28498873	55	71	cognitive status	T033	C0945985
28498873	79	97	general population	T098	C0683971
28498873	98	110	Associations	T080	C0439849
28498873	119	128	androgens	T121,T125	C0002844
28498873	133	152	depressive symptoms	T184	C0086132
28498873	179	194	cross-sectional	T062	C0010362
28498873	199	220	patient-based studies	T062	C0242481
28498873	222	239	Longitudinal data	T078	C1511726
28498873	251	263	participants	T098	C0679646
28498873	271	286	Study of Health	T062	C0242481
28498873	290	299	Pomerania	UnknownType	C0681784
28498873	313	319	assess	T058	C0184514
28498873	320	323	sex	T032	C1522384
28498873	326	334	specific	T080	C0205369
28498873	335	347	associations	T080	C0439849
28498873	351	359	baseline	T081	C1442488
28498873	360	365	total	T080	C0439810
28498873	370	374	free	T080	C1996904
28498873	375	387	testosterone	T109,T121,T125	C0039601
28498873	389	404	androstenedione	T109,T121,T125	C0002860
28498873	409	437	sex hormone-binding globulin	T116,T123	C0036883
28498873	443	451	incident	T067	C1551358
28498873	452	471	depressive symptoms	T184	C0086132
28498873	476	492	cognitive status	T033	C0945985
28498873	507	511	year	T079	C0439234
28498873	512	521	follow-up	T058	C1522577
28498873	531	534	sex	T032	C1522384
28498873	537	545	specific	T080	C0205369
28498873	546	557	differences	T080	C1705242
28498873	561	580	depressive symptoms	T184	C0086132
28498873	581	591	prevalence	T081	C0220900
28498873	595	603	baseline	T081	C1442488
28498873	605	610	women	T098	C0043210
28498873	619	622	men	T098	C0025266
28498873	631	655	cross-sectional analyses	T062	C0010362
28498873	663	665	no	T033	C1513916
28498873	666	678	associations	T080	C0439849
28498873	687	690	sex	T032	C1522384
28498873	691	699	hormones	T125	C0019932
28498873	704	723	depressive symptoms	T184	C0086132
28498873	728	762	age-adjusted longitudinal analyses	UnknownType	C0815265
28498873	764	782	total testosterone	T109,T121,T125	C0039601
28498873	787	802	associated with	T080	C0332281
28498873	803	811	incident	T067	C1551358
28498873	812	831	depressive symptoms	T184	C0086132
28498873	833	846	relative risk	T081	C0242492
28498873	853	857	year	T079	C0439234
28498873	858	867	follow-up	T058	C1522577
28498873	879	898	confidence interval	T081	C0009667
28498873	923	944	age-adjusted analyses	UnknownType	C0815265
28498873	954	962	positive	T033	C1446409
28498873	963	974	association	T080	C0439849
28498873	983	1011	sex hormone-binding globulin	T116,T123	C0036883
28498873	1016	1032	cognitive status	T033	C0945985
28498873	1036	1039	men	T098	C0025266
28498873	1041	1054	β-coefficient	T081	C1707429
28498873	1059	1077	standard deviation	T081	C0871420
28498873	1089	1108	confidence interval	T081	C0009667
28498873	1125	1130	women	T098	C0043210
28498873	1145	1157	associations	T080	C0439849
28498873	1161	1176	androstenedione	T109,T121,T125	C0002860
28498873	1182	1190	baseline	T081	C1442488
28498873	1191	1210	depressive symptoms	T184	C0086132
28498873	1212	1225	relative risk	T081	C0242492
28498873	1237	1256	confidence interval	T081	C0009667
28498873	1302	1314	associations	T080	C0439849
28498873	1330	1354	multivariable adjustment	T062	C0242481
28498873	1368	1384	population-based	T062	C1709599
28498873	1386	1404	longitudinal study	UnknownType	C0815265
28498873	1414	1421	inverse	T080	C0439850
28498873	1422	1434	associations	T080	C0439849
28498873	1443	1446	sex	T032	C1522384
28498873	1447	1455	hormones	T125	C0019932
28498873	1460	1479	depressive symptoms	T184	C0086132
28498873	1513	1537	multivariable adjustment	T062	C0242481
28498873	1566	1578	associations	T080	C0439849
28498873	1588	1599	independent	T078	C0085862
28498873	1603	1611	relevant	T080	C2347946
28498873	1612	1623	confounders	T169	C0009673
28498873	1634	1649	body mass index	T201	C1305855
28498873	1651	1658	smoking	T055	C0037369
28498873	1663	1682	physical inactivity	T056	C3890554
28498873	1715	1723	incident	T067	C1551358
28498873	1724	1733	endpoints	T080	C2349179
28498873	1741	1777	non-clinical population-based sample	T062	C0242481
28498873	1790	1807	statistical power	T062	C0814897
28498873	1812	1819	reduced	T080	C0392756
28498873	1834	1840	detect	T033	C0442726
28498873	1843	1868	statistically significant	T081	C0237881
28498873	1869	1875	effect	T080	C1280500